
    
      Patients enrolled in Qilu Hospital of Shandong University (Jinan, China), Chinese PLA General
      Hospital Hospital (Beijing, China) and Peking University First Hospital (Beijing, China) are
      designed as the development cohort to derive the risk prediction models of ischemic and
      bleeding events. Patients enrolled in Peking University Third Hospital ( Beijing, China) Zibo
      Central hospital (Zibo, China) are designed as the independent validation cohort.
    
  